Your session is about to expire
← Back to Search
EQUIPED-ADRD Intervention for Dementia (EQUIPED-ADRD Trial)
N/A
Waitlist Available
Led By Joshua Chodosh, MD, MSHS, FACP
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to month 24
Awards & highlights
EQUIPED-ADRD Trial Summary
This trial will develop and test an intervention to improve care quality for patients with Alzheimer's disease and related dementia who also have diabetes. The intervention will feature use of consensus decisional guidance for the medical management of diabetes, provider workflow enhancements supported by a panel manager, electronic health record decision support and feedback, and PCP collaborative learning.
Eligible Conditions
- Dementia
- Diabetes
- Alzheimer's Disease
EQUIPED-ADRD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to month 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to month 24
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of Patients Who Reach Consensus Target HBA1c
EQUIPED-ADRD Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention (INT)Experimental Treatment1 Intervention
(10 clinic sites and ~500 patients) which includes practice guidelines for clinicians, provider education, electronic health record support for quality DM-ADRD care, information about community/clinical resources, ongoing targeted provider feedback, and a panel manager (PM)
Group II: Control (CON)Placebo Group1 Intervention
During training the CON providers will be encouraged to do cognitive screening as well as follow the guidelines in general.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EQUIPED-ADRD Intervention
2018
N/A
~360
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,373 Previous Clinical Trials
840,765 Total Patients Enrolled
17 Trials studying Dementia
67,598 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,692 Previous Clinical Trials
28,026,859 Total Patients Enrolled
275 Trials studying Dementia
23,628,070 Patients Enrolled for Dementia
Joshua Chodosh, MD, MSHS, FACPPrincipal InvestigatorNYU Langone Health
Share this study with friends
Copy Link
Messenger